Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dinny Wallis

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Current Opinion in Rheumatology|May 16, 2014
Infection risk and biologics: current updateDinny Wallis
Rheumatic Diseases Clinics of North America|December 2, 2014
Recognition of preclinical and early disease in axial spondyloarthritisDinny Wallis, Robert D Inman
Rheumatology (Oxford, England)|August 16, 2014
Tumour necrosis factor inhibitor therapy and infection risk in axial spondyloarthritis: results from a longitudinal observational cohortDinny Wallis, Arane Thavaneswaran, Nigil Haroon, et al.
The Journal of the Royal College of Physicians of Edinburgh|November 27, 2025
An unusual case of cutaneous tuberculosis and paradoxical TB in a patient with spondyloarthritis treated with adalimumabAntia Garcia Fernandez, Alice Sinclair, Paul Elkington, et al.
The Journal of Rheumatology|November 5, 2013
Ankylosing spondylitis and nonradiographic axial spondyloarthritis: part of a common spectrum or distinct diseases?Dinny Wallis, Nigil Haroon, Renise Ayearst, et al.
BMC Musculoskeletal Disorders|April 8, 2020
Amongst patients taking biologic therapies for axial spondyloarthritis, which factors are associated with work non-participation?Tom Nadin, Dinny Wallis, Christopher R Holroyd, et al.
The Journal of Rheumatology|November 18, 2011
The ClASsification for Psoriatic ARthritis (CASPAR) criteria--a retrospective feasibility, sensitivity, and specificity studyWilliam Tillett, Luisa Costa, Deepak Jadon, et al.
Arthritis Research & Therapy|November 30, 2013
Elevated serum anti-flagellin antibodies implicate subclinical bowel inflammation in ankylosing spondylitis: an observational studyDinny Wallis, Arundip Asaduzzaman, Michael Weisman, et al.
Arthritis Care & Research|October 17, 2015
Clinical Efficacy of Celecoxib Compared to Acetaminophen in Chronic Nonspecific Low Back Pain: Results of a Randomized Controlled TrialMohamed K Bedaiwi, Ismail Sari, Dinny Wallis, et al.
Rheumatology (Oxford, England)|October 25, 2012
Exploring ankylosing spondylitis-associated ERAP1, IL23R and IL12B gene polymorphisms in subphenotypes of psoriatic arthritisDeepak Jadon, William Tillett, Dinny Wallis, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Current Opinion in Rheumatology|May 16, 2014
Infection risk and biologics: current updateDinny Wallis
Rheumatic Diseases Clinics of North America|December 2, 2014
Recognition of preclinical and early disease in axial spondyloarthritisDinny Wallis, Robert D Inman
Rheumatology (Oxford, England)|August 16, 2014
Tumour necrosis factor inhibitor therapy and infection risk in axial spondyloarthritis: results from a longitudinal observational cohortDinny Wallis, Arane Thavaneswaran, Nigil Haroon, et al.
The Journal of the Royal College of Physicians of Edinburgh|November 27, 2025
An unusual case of cutaneous tuberculosis and paradoxical TB in a patient with spondyloarthritis treated with adalimumabAntia Garcia Fernandez, Alice Sinclair, Paul Elkington, et al.
The Journal of Rheumatology|November 5, 2013
Ankylosing spondylitis and nonradiographic axial spondyloarthritis: part of a common spectrum or distinct diseases?Dinny Wallis, Nigil Haroon, Renise Ayearst, et al.
BMC Musculoskeletal Disorders|April 8, 2020
Amongst patients taking biologic therapies for axial spondyloarthritis, which factors are associated with work non-participation?Tom Nadin, Dinny Wallis, Christopher R Holroyd, et al.
The Journal of Rheumatology|November 18, 2011
The ClASsification for Psoriatic ARthritis (CASPAR) criteria--a retrospective feasibility, sensitivity, and specificity studyWilliam Tillett, Luisa Costa, Deepak Jadon, et al.
Arthritis Research & Therapy|November 30, 2013
Elevated serum anti-flagellin antibodies implicate subclinical bowel inflammation in ankylosing spondylitis: an observational studyDinny Wallis, Arundip Asaduzzaman, Michael Weisman, et al.
Arthritis Care & Research|October 17, 2015
Clinical Efficacy of Celecoxib Compared to Acetaminophen in Chronic Nonspecific Low Back Pain: Results of a Randomized Controlled TrialMohamed K Bedaiwi, Ismail Sari, Dinny Wallis, et al.
Rheumatology (Oxford, England)|October 25, 2012
Exploring ankylosing spondylitis-associated ERAP1, IL23R and IL12B gene polymorphisms in subphenotypes of psoriatic arthritisDeepak Jadon, William Tillett, Dinny Wallis, et al.
Pageof 2